» Articles » PMID: 39407977

Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Oct 16
PMID 39407977
Authors
Affiliations
Soon will be listed here.
Abstract

: Predicting stroke outcomes in acute ischemic stroke (AIS) can be challenging, especially for patients with large vessel occlusion (LVO). Available tools such as infarct volume and the National Institute of Health Stroke Scale (NIHSS) have shown limited accuracy in predicting outcomes for this specific patient population. The present study aimed to confirm whether sudden metabolic changes due to blood-brain barrier (BBB) disruption during LVO reflect differences in circulating metabolites and RNA between small and large core strokes. The second objective was to evaluate whether integrating molecular markers with existing neurological and imaging tools can enhance outcome predictions in LVO strokes. : The infarction volume in patients was measured using magnetic resonance diffusion-weighted images, and the 90-day stroke outcome was defined by a modified Rankin Scale (mRS). Differential expression patterns of miRNAs were identified by RNA sequencing of serum-driven exosomes. Nuclear magnetic resonance (NMR) spectroscopy was used to identify metabolites associated with AIS with small and large infarctions. : We identified 41 miRNAs and 11 metabolites to be significantly associated with infarct volume in a multivariate regression analysis after adjusting for the confounders. Eight miRNAs and ketone bodies correlated significantly with infarct volume, NIHSS (severity), and mRS (outcome). Through integrative analysis of clinical, radiological, and omics data using machine learning, our study identified 11 top features for predicting stroke outcomes with an accuracy of 0.81 and AUC of 0.91. : Our study provides a future framework for advancing stroke therapeutics by incorporating molecular markers into the existing neurological and imaging tools to improve predictive efficacy and enhance patient outcomes.

Citing Articles

Novel Metabolites as Potential Indicators of Recovery After Large Vessel Occlusion Stroke: A Pilot Study.

Sidorov E, Smith K, Xu C, Sanghera D Neurol Int. 2025; 17(2).

PMID: 39997661 PMC: 11858463. DOI: 10.3390/neurolint17020030.

References
1.
Saver J, Filip B, Hamilton S, Yanes A, Craig S, Cho M . Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke. 2010; 41(5):992-5. PMC: 2930146. DOI: 10.1161/STROKEAHA.109.571364. View

2.
Rout M, Malone-Perez M, Park G, Lerner M, Frazer J, Apple B . Contribution of circulating Mfge8 to human T2DM and cardiovascular disease. Gene. 2024; 927:148712. PMC: 11348863. DOI: 10.1016/j.gene.2024.148712. View

3.
Fang W, Fan Y, Fa Z, Xu J, Yu H, Li P . microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget. 2017; 8(8):13253-13263. PMC: 5355093. DOI: 10.18632/oncotarget.14710. View

4.
Chamorro A, Brown S, Amaro S, Hill M, Muir K, Dippel D . Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke. Stroke. 2019; 50(3):690-696. DOI: 10.1161/STROKEAHA.118.023769. View

5.
Zhong S, Cui M, Gao Y, Cao X, Chen B, Wen X . MicroRNA-144 promotes remote limb ischemic preconditioning-mediated neuroprotection against ischemic stroke via PTEN/Akt pathway. Acta Neurol Belg. 2020; 121(1):95-106. DOI: 10.1007/s13760-020-01500-5. View